Recruiting Hepatitis B Studies in Buenos Aires
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
This is a global multi-center, long-term follow-up study to assess durability of efficacy, as measured by maintenance of treatment response from the parent study, in participants who participated in a...
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
This study will evaluate the efficacy and safety of bepirovirsen compared to placebo in participants with human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co-infection....
About Hepatitis B Clinical Trials in Buenos Aires
Hepatitis B is a liver infection caused by the hepatitis B virus that can become chronic and lead to cirrhosis, liver failure, or liver cancer. A vaccine can prevent infection. Treatment for chronic hepatitis B includes antiviral medications that suppress the virus.
There are currently 2 hepatitis b clinical trials recruiting participants in Buenos Aires, . These studies are seeking a combined 600 participants. Research is being sponsored by GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hepatitis B Clinical Trials in Buenos Aires — FAQ
Are there hepatitis b clinical trials in Buenos Aires?
Yes, there are 2 hepatitis b clinical trials currently recruiting in Buenos Aires, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Buenos Aires?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buenos Aires research site will contact you about next steps.
Are clinical trials in Buenos Aires free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buenos Aires studies also compensate for your time and travel.
What hepatitis b treatments are being tested?
The 2 active trials in Buenos Aires are testing new therapies including novel drugs, biologics, and treatment approaches for hepatitis b.
Data updated March 2, 2026 from ClinicalTrials.gov